Zhenghai Bio-tech won the honorary title of "National IPR Demonstration Enterprise"

12-17-2019 visits:1220


On November 29, 2019, the National Intellectual Property Administration issued the Announcement of the Review and Re-inspection Results of National Intellectual Demonstration Enterprises of Property Advantages in 2019, in which Zhenghai Bio-tech was listed.

  The National IPR Demonstration Enterprise is the qualification of the state for the enterprises with outstanding contributions in the creation, application, protection and management of intellectual property rights, which is the highest evaluation made by the state to the intellectual property right management of enterprises. The applicant enterprises must be an advantageous enterprise of regional influence, and must have excellent performance in the national assessment of intellectual-property advantageous enterprise for three consecutive years before they can have the qualification as the applicants.

  In 2014, Zhenghai Bio-tech implemented the Enterprise Intellectual Property Management, highlighted the improvement of the Company's intellectual property advantages, and won multiple national and provincial patent awards, as well as the titles of "Model Enterprise of Intellectual Property in Shandong Province", "National Enterprise with Intellectual Property Advantage", "Pilot Enterprise of Industrial Enterprise Intellectual Property Application", etc. The affirmation of "National IPR Demonstration Enterprise" is the state's recognition for the intellectual property management of Zhenghai Bio-tech. Zhenghai Bio-tech will continue to emphasize the improvement of the strategic management ability for intellectual property, creation ability of intellectual property, operation ability of intellectual property, and protection ability of intellectual property, improve the comprehensive competitiveness and innovation ability of the Company in an all-round way, and play a leading and demonstration role in various industrial fields and demonstration areas, and strive to construct a benchmarking demonstration enterprise of intellectual property rights in the field of medical devices.